GAIN THERAPEUTICS, INC (GANX) Operating income 2020–2025
GAIN THERAPEUTICS, INC (GANX) annual operating income history from SEC filings — each fiscal year as reported.
-$18.7MFY2025 · since FY2020: -$3.5M → -$18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.7M | +8.1% |
| FY2024 | -$20.4M | +8.5% |
| FY2023 | -$22.3M | -25.2% |
| FY2022 | -$17.8M | -28.6% |
| FY2021 | -$13.8M | -297.4% |
| FY2020 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GANX financial trends
GANX RevenueGANX Net incomeGANX Net marginGANX Gross profitGANX Gross marginGANX Operating marginGANX Operating cash flowGANX Free cash flowGANX Capital expendituresGANX Return on equityGANX Stock buybacksGANX Dividends paidGANX Total assetsGANX Total liabilitiesGANX Shareholders’ equityGANX overview →